78 related articles for article (PubMed ID: 26431176)
21. Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen.
Basu S; Combe K; Kwiatkowski F; Caldefie-Chézet F; Penault-Llorca F; Bignon YJ; Vasson MP
PLoS One; 2015; 10(10):e0138443. PubMed ID: 26431176
[TBL] [Abstract][Full Text] [Related]
22. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
Oliveira VM; Piato S; Silva MA
Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
[TBL] [Abstract][Full Text] [Related]
23. Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.
Brueggemeier RW; Díaz-Cruz ES
Minerva Endocrinol; 2006 Mar; 31(1):13-26. PubMed ID: 16498361
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer.
Salhab M; Singh-Ranger G; Mokbel R; Jouhra F; Jiang WG; Mokbel K
J Surg Oncol; 2007 Oct; 96(5):424-8. PubMed ID: 17657731
[TBL] [Abstract][Full Text] [Related]
25. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
[TBL] [Abstract][Full Text] [Related]
26. The obesity-inflammation-eicosanoid axis in breast cancer.
Vona-Davis L; Rose DP
J Mammary Gland Biol Neoplasia; 2013 Dec; 18(3-4):291-307. PubMed ID: 24170420
[TBL] [Abstract][Full Text] [Related]
27. Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency.
Atkinson RL; Yang WT; Rosen DG; Landis MD; Wong H; Lewis MT; Creighton CJ; Sexton KR; Hilsenbeck SG; Sahin AA; Brewster AM; Woodward WA; Chang JC
Breast Cancer Res; 2013; 15(5):R77. PubMed ID: 24008095
[TBL] [Abstract][Full Text] [Related]
28. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry.
Inwald EC; Klinkhammer-Schalke M; Hofstädter F; Zeman F; Koller M; Gerstenhauer M; Ortmann O
Breast Cancer Res Treat; 2013 Jun; 139(2):539-52. PubMed ID: 23674192
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.
Cai J; Guan H; Fang L; Yang Y; Zhu X; Yuan J; Wu J; Li M
J Clin Invest; 2013 Feb; 123(2):566-79. PubMed ID: 23321667
[TBL] [Abstract][Full Text] [Related]
30. Effects of enriched environment on COX-2, leptin and eicosanoids in a mouse model of breast cancer.
Nachat-Kappes R; Pinel A; Combe K; Lamas B; Farges MC; Rossary A; Goncalves-Mendes N; Caldefie-Chezet F; Vasson MP; Basu S
PLoS One; 2012; 7(12):e51525. PubMed ID: 23272114
[TBL] [Abstract][Full Text] [Related]
31. Eicosanoids and adipokines in breast cancer: from molecular mechanisms to clinical considerations.
Basu S; Nachat-Kappes R; Caldefie-Chézet F; Vasson MP
Antioxid Redox Signal; 2013 Jan; 18(3):323-60. PubMed ID: 22746381
[TBL] [Abstract][Full Text] [Related]
32. Obesity and breast cancer: mechanisms and therapeutic implications.
Brown KA; Simpson ER
Front Biosci (Elite Ed); 2012 Jun; 4(7):2515-24. PubMed ID: 22652657
[TBL] [Abstract][Full Text] [Related]
33. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women.
Subbaramaiah K; Morris PG; Zhou XK; Morrow M; Du B; Giri D; Kopelovich L; Hudis CA; Dannenberg AJ
Cancer Discov; 2012 Apr; 2(4):356-65. PubMed ID: 22576212
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer.
Richardsen E; Uglehus RD; Johnsen SH; Busund LT
BMC Res Notes; 2012 Feb; 5():110. PubMed ID: 22353218
[TBL] [Abstract][Full Text] [Related]
35. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
Yan D; Avtanski D; Saxena NK; Sharma D
J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
